Femme Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
• To demonstrate that avelumab given alone or in combination with PLD is superior to PLD alone in prolonging OS in patients with platinum -resistant/platinum-refractory ovarian cancer.
Critère d'inclusion
- Ovarian Cancer